InterCure Ltd. , together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally.
Intercure stock last closed at $1.93, up 6.63% from the previous day, and has decreased 73.38% in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.34 percentage points. Intercure stock is currently +11.56% from its 52-week low of $1.73, and -74.57% from its 52-week high of $7.59.
As of Mar 21, 2023, there are 45.13M INCR shares outstanding. The market value of INCR is $87.11M. In the past 24 hours, 64,109 INCR shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy INCR stock.
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your share purchase by signing up for an account with eToro today.
Open eToro AccountNow that you've chosen the right brokerage, it's time to fill out some personal information so you are able to invest in INCR today.
Now that you have created your account on one of the best stock trading apps, you need to deposit funds:
Watch the tutorial below to see the process of transferring money into your new brokerage account.
Once you have chosen the best place to buy Intercure stock, it's crucial to analyze their stock prior to buying, so you truly comprehend the risk as well as the opportunity.
WallStreetZen was created to help average investors perform more accurate fundamental analysis.
You can see all of the due diligence checks on INCR's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge INCR's intrinsic value.
Using relative valuations methods:
You can do more valuation analysis on INCR's stock here.
Out of 2 Wall Street analysts who give recommendations on INCR, the consensus analyst rating on Intercure is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Intercure stock forecast page.
Last year, INCR revenue was $104.25M. Over the past 1 years, INCR's revenue has grown by 95.18% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 19.45%.
Dig into INCR's earnings and revenue performance here.
In the last 12 months, insiders at INCR have not bought or sold any shares.
Dig into more about who owns INCR stock here.
No, Intercure doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
There are two primary types of orders:
Click the Open button and your broker will place your order.
If you need more help investing in stocks on eToro, click the how to video below:
Now that you own some INCR stock, you'll want to keep up with your investment.
Create a watchlist to get alerted to the latest events about your INCR stock.
To reiterate, here are the 6 steps for buying Intercure stock:
If you need a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Intercure, create your watchlist below.